Pages that link to "Q40486730"
Jump to navigation
Jump to search
The following pages link to Trastuzumab down-regulates Bcl-2 expression and potentiates apoptosis induction by Bcl-2/Bcl-XL bispecific antisense oligonucleotides in HER-2 gene--amplified breast cancer cells. (Q40486730):
Displaying 23 items.
- Artemin, a member of the glial cell line-derived neurotrophic factor family of ligands, is HER2-regulated and mediates acquired trastuzumab resistance by promoting cancer stem cell-like behavior in mammary carcinoma cells (Q33718457) (← links)
- Expression of the apoptosis-related genes BCL-2 and BAD in human breast carcinoma and their associated relationship with chemosensitivity (Q34075056) (← links)
- ERBB3 knockdown induces cell cycle arrest and activation of Bak and Bax-dependent apoptosis in colon cancer cells (Q34104165) (← links)
- The mitogen-activated protein kinase (MAPK) cascade controls phosphatase and tensin homolog (PTEN) expression through multiple mechanisms (Q34244242) (← links)
- Regulation of anti-apoptotic signaling by Kruppel-like factors 4 and 5 mediates lapatinib resistance in breast cancer. (Q35274741) (← links)
- Targeting Bcl-2 in Herceptin-Resistant Breast Cancer Cell Lines (Q35599629) (← links)
- The chemomodulatory effects of resveratrol and didox on herceptin cytotoxicity in breast cancer cell lines. (Q35834363) (← links)
- Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy (Q36558024) (← links)
- Survival of HER2-Positive Breast Cancer Cells: Receptor Signaling to Apoptotic Control Centers (Q37194856) (← links)
- Leptin-signaling inhibition results in efficient anti-tumor activity in estrogen receptor positive or negative breast cancer (Q37277170) (← links)
- Gene expression profile and response to trastuzumab-docetaxel-based treatment in breast carcinoma. (Q37401557) (← links)
- PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer (Q37655023) (← links)
- Absence of p53 gene expression in selenium molecular prevention of chemically induced hepatocarcinogenesis in rats (Q38548673) (← links)
- 188Re-HYNIC-trastuzumab enhances the effect of apoptosis induced by trastuzumab in HER2-overexpressing breast cancer cells. (Q38954976) (← links)
- Aberrant activation of the mTOR pathway and anti-tumour effect of everolimus on oesophageal squamous cell carcinoma (Q39396713) (← links)
- Inhibition of Bcl-2 and Bcl-X enhances chemotherapy sensitivity in hepatoblastoma cells (Q39672272) (← links)
- Dual mechanisms of sHA 14-1 in inducing cell death through endoplasmic reticulum and mitochondria. (Q39832035) (← links)
- Lapatinib, a HER2 tyrosine kinase inhibitor, induces stabilization and accumulation of HER2 and potentiates trastuzumab-dependent cell cytotoxicity (Q39908130) (← links)
- Release of HER2 repression of trefoil factor 3 (TFF3) expression mediates trastuzumab resistance in HER2+/ER+ mammary carcinoma (Q47114555) (← links)
- Osthole Synergizes With HER2 Inhibitor, Trastuzumab in HER2-Overexpressed N87 Gastric Cancer by Inducing Apoptosis and Inhibition of AKT-MAPK Pathway (Q59807317) (← links)
- STAT6 knockdown using multiple siRNA sequences inhibits proliferation and induces apoptosis of human colorectal and breast cancer cell lines (Q64058561) (← links)
- Therapeutic potential of combined BRAF/MEK blockade in BRAF-wild type preclinical tumor models (Q89478898) (← links)
- Chemoradiotherapy response prediction model by proteomic expressional profiling in patients with locally advanced cervical cancer (Q89924984) (← links)